Results 51 to 60 of about 2,249 (120)
New Anticomplement Drugs in Nephrology: Mechanism and Indication
Background: The complement system is a key component of innate immunity, critical for pathogen defense, inflammation, and immune regulation.
Lucia Macciò +5 more
doaj +1 more source
Background/Aims: Diabetic kidney disease (DKD) is one of the most frequent microvascular complications of diabetes and is the leading cause of end-stage kidney disease worldwide.
Siyar Erdogmus +11 more
doaj +1 more source
Type 2 Diabetes Mellitus: Molecular Pathogenesis and Therapeutic Interventions
This graphical summary illustrates the multiorgan therapeutic landscape for Type 2 diabetes mellitus (T2D), integrating molecular pathogenesis with modern treatment strategies. It depicts how current interventions, including SGLT2 inhibitors, GLP‐1 receptor agonists, and insulin secretagogues, target key organs—kidney, pancreas, gastrointestinal tract,
Shinuan Fei +9 more
wiley +1 more source
ABSTRACT The rare X‐linked female‐restricted Hardikar syndrome (HDKR, OMIM # 301068) is characterized by multiple congenital anomalies including orofacial clefts, gastrointestinal, genitourinary, and cardiac anomalies, but cognitive and neurobehavioral development is rarely impaired.
Tinne Warmoeskerken +4 more
wiley +1 more source
Living-donor kidney transplantation (KT) offers the best outcomes for patients with kidney failure (KF). However, recurrence of primary kidney disease in the allograft remains a major concern and represents 1 of the leading causes of graft loss ...
Catherine Verhellen +7 more
doaj +1 more source
Membranous Nephropathy: Advances in Diagnosis and Treatment, with an Eye on PLA2R1-Negative Forms
Membranous nephropathy (MN) is an immune complex-mediated glomerular disease defined by sub-epithelial deposits that trigger complement activation and podocyte injury. Its pathogenesis reflects loss of immune tolerance and may present as a kidney-limited
Micaela Anna Casiraghi +7 more
doaj +1 more source
BackgroundThe M-type phospholipase A2 receptor (PLA2R) antibody positivity is considered a specific serological marker for idiopathic membranous nephropathy (IMN), and its presence in class V lupus nephritis (LN) is rare.
Bo Shen, Cheng Peng, Weicheng Xiao
doaj +1 more source
A membranous nephropathy variant mimicking minimal change disease
This study characterizes a novel disease pattern of membranous nephropathy (MN) that exhibits overlapping clinicopathological features with minimal change disease (MCD), termed ‘MCD‐like MN’.
Chuqi Pan +8 more
doaj +1 more source
Prevalence and Factors Predicting Nondiabetic Kidney Disease in Type 2 Diabetic Patients
Background: Renal involvement in type 2 diabetes is mostly presumed to be due to diabetic nephropathy; however, a significant majority of diabetic patients can have pure nondiabetic kidney disease (NDKD) or NDKD superimposed on diabetic kidney disease ...
Vignesh Subramani +5 more
doaj +1 more source
Renal biopsy remains the gold standard for diagnosing membranous nephropathy (MN). Recent studies have suggested that renal biopsy can be replaced with the serum phospholipase A2 receptor (PLA2R) antibody test for MN diagnosis in patients with nephrotic ...
Shan Lu +5 more
doaj +1 more source

